Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
26 studies found for:    "Andersen-Tawil syndrome" OR "Long QT Syndrome"
Show Display Options
Rank Status Study
21 Not yet recruiting Worm Study: Modifier Genes in Sudden Cardiac Death
Conditions: Brugada Syndrome;   Long QT Syndrome 3
Interventions: Procedure: Dermal biopsy;   Drug: Ajmaline challenge;   Genetic: Whole-exome sequencing
22 Completed Genetic Sources of Variability of the Adaptation of the Ventricular Repolarisation
Condition: Healthy Volunteers
Intervention: Drug: Sotalol 80 mg
23 Recruiting Effect of GS-6615 on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT-3 Syndrome
Condition: Long QT-3 Syndrome
Interventions: Drug: GS-6615;   Drug: Placebo to match GS-6615
24 Terminated Infant Medical Records: Case Report Proposal
Condition: Congenital Disorders
Intervention:
25 Completed The Effect of General Anesthesia on the Risk for Arrhythmia
Condition: Arrhythmia
Intervention:
26 Not yet recruiting Effect of GS-6615 on QT, Safety, and Tolerability in Adults With Long QT2 Syndrome
Condition: LQT2 Syndrome
Interventions: Drug: GS-6615;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-26) Next Page   
Indicates status has not been verified in more than two years